Richard E.B. Seftor

11.8k total citations · 1 hit paper
101 papers, 9.4k citations indexed

About

Richard E.B. Seftor is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Richard E.B. Seftor has authored 101 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 31 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Richard E.B. Seftor's work include Cell Adhesion Molecules Research (27 papers), Angiogenesis and VEGF in Cancer (23 papers) and Cancer Cells and Metastasis (22 papers). Richard E.B. Seftor is often cited by papers focused on Cell Adhesion Molecules Research (27 papers), Angiogenesis and VEGF in Cancer (23 papers) and Cancer Cells and Metastasis (22 papers). Richard E.B. Seftor collaborates with scholars based in United States, Canada and Belgium. Richard E.B. Seftor's co-authors include Mary J.C. Hendrix, Elisabeth A. Seftor, Angela R. Hess, Dawn A. Kirschmann, Lynne‐Marie Postovit, Naira V. Margaryan, William G. Stetler‐Stevenson, Lynn M. Gruman, Lynn M.G. Gardner and Katrina T. Trevor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature reviews. Cancer.

In The Last Decade

Richard E.B. Seftor

100 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

2003 666 citations Mary J.C. Hendrix, Elisabeth A. Seftor et al. Nature reviews. Cancer profile →

Peers

Countries citing papers authored by Richard E.B. Seftor

Since Specialization

Citations

This map shows the geographic impact of Richard E.B. Seftor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E.B. Seftor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E.B. Seftor more than expected).

Fields of papers citing papers by Richard E.B. Seftor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E.B. Seftor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E.B. Seftor. The network helps show where Richard E.B. Seftor may publish in the future.

Co-authorship network of co-authors of Richard E.B. Seftor

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E.B. Seftor. A scholar is included among the top collaborators of Richard E.B. Seftor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E.B. Seftor. Richard E.B. Seftor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Stem Cell Phenotype of Aggressive Breast Cancer Cells 2019 ·Cancers ·Naira V. Margaryan, Hannah Hazard‐Jenkins, Mohamad A. Salkeni, Matthew B. Smolkin, (unknown), Sijin Wen, Elisabeth A. Seftor, Richard E.B. Seftor, Mary J.C. Hendrix	9
2	Targeting the Stem Cell Properties of Adult Breast Cancer Cells: Using Combinatorial Strategies to Overcome Drug Resistance 2017 ·PubMed ·Naira V. Margaryan, Elisabeth A. Seftor, Richard E.B. Seftor, Mary J.C. Hendrix	14
3	Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells 2016 ·Laboratory Investigation ·Mary J.C. Hendrix, Irawati Kandela, Andrew P. Mazar, Elisabeth A. Seftor, Richard E.B. Seftor, Naira V. Margaryan, Luigi Strizzi, Gëorge F. Murphy, Georgina V. Long, Richard A. Scolyer	12
4	Melanoma Tumor Cell Heterogeneity: A Molecular Approach to Study Subpopulations Expressing the Embryonic Morphogen Nodal 2014 ·Seminars in Oncology ·Elisabeth A. Seftor, Richard E.B. Seftor, (unknown), Gina Kirsammer, Naira V. Margaryan, (unknown), Mary J.C. Hendrix	32
5	Tumor Cell Vasculogenic Mimicry 2012 ·American Journal Of Pathology ·Richard E.B. Seftor, Angela R. Hess, Elisabeth A. Seftor, Dawn A. Kirschmann, Katharine M. Hardy, Naira V. Margaryan, Mary J.C. Hendrix	228
6	Cancer hallmarks in induced pluripotent cells: New insights 2010 ·Journal of Cellular Physiology ·Sergey Malchenko, Vasiliy Galat, Elisabeth A. Seftor, Elio F. Vanin, Fabrício F. Costa, Richard E.B. Seftor, Marcelo B. Soares, Mary J.C. Hendrix	36
7	Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention 2009 ·Expert Review of Dermatology ·Luigi Strizzi, Lynne‐Marie Postovit, Naira V. Margaryan, (unknown), Jules Gadiot, Christian U. Blank, Richard E.B. Seftor, Elisabeth A. Seftor, Mary J.C. Hendrix	56
8	Reprogramming metastatic tumour cells with embryonic microenvironments 2007 ·Nature reviews. Cancer ·Mary J.C. Hendrix, Elisabeth A. Seftor, Richard E.B. Seftor, Jennifer C. Kasemeier‐Kulesa, Paul M. Kulesa, Lynne‐Marie Postovit	372
9	The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment 2006 ·Journal of Cellular and Molecular Medicine ·Elisabeth A. Seftor, Paul S. Meltzer, D A Kirschmann, Naira V. Margaryan, Richard E.B. Seftor, Mary J.C. Hendrix	26
10	VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: Implications for vasculogenic mimicry 2006 ·Cancer Biology & Therapy ·Angela R. Hess, Elisabeth A. Seftor, Lynn M. Gruman, Michael S. Kinch, Richard E.B. Seftor, Mary J.C. Hendrix	143
11	Focal Adhesion Kinase Promotes the Aggressive Melanoma Phenotype 2005 ·Cancer Research ·Angela R. Hess, Lynne‐Marie Postovit, Naira V. Margaryan, Elisabeth A. Seftor, Galen B. Schneider, Richard E.B. Seftor, Brian J. Nickoloff, Mary J.C. Hendrix	123
12	Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma breakdown → 2003 ·Nature reviews. Cancer ·Mary J.C. Hendrix, Elisabeth A. Seftor, Angela R. Hess, Richard E.B. Seftor	666
13	Remodeling of the Microenvironment by Aggressive Melanoma Tumor Cells 2003 ·Annals of the New York Academy of Sciences ·Mary J.C. Hendrix, Elisabeth A. Seftor, Dawn A. Kirschmann, Vito Quaranta, Richard E.B. Seftor	91
14	Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells 2002 ·Biochemical and Biophysical Research Communications ·Valerie Odero-Marah, Zhila Khalkhali‐Ellis, Galen B. Schneider, Elisabeth A. Seftor, Richard E.B. Seftor, John G. Koland, Mary J.C. Hendrix	21
15	Molecular Determinants of Ovarian Cancer Plasticity 2001 ·American Journal Of Pathology ·Anil K. Sood, E. A. Seftor, Mavis S. Fletcher, Lynn M.G. Gardner, Paul M. Heidger, (unknown), Richard E.B. Seftor, Mary J.C. Hendrix	218
16	Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells 2000 ·Breast Cancer Research ·Mary J.C. Hendrix, Elisabeth A. Seftor, Dawn A. Kirschmann, Richard E.B. Seftor	81
17	Anin vitro model for studying mechanisms underlying synoviocyte-mediated cartilage invasion in rheumatoid arthritis 1996 ·Pathology & Oncology Research ·(unknown), David E. Yocum, Rocky S. Tuan, (unknown), Elisabeth A. Seftor, Richard E.B. Seftor, (unknown), Terry L. Moore, Mary J.C. Hendrix	10
18	Corticosteroid Treatment and Trabecular Meshwork Proteases in Cell and Organ Culture Supernatants 1993 ·Experimental Eye Research ·Robert W. Snyder, W. Daniel Stamer, Theresa R. Kramer, Richard E.B. Seftor	84
19	Coexpression of Vimentin and Keratins by Human Melanoma Tumor Cells: Correlation With Invasive and Metastatic Potential 1992 ·JNCI Journal of the National Cancer Institute ·Mary J.C. Hendrix, E. A. Seftor, (unknown), Richard E.B. Seftor, Ray B. Nagle, Kathleen McDaniel, Stanley P. L. Leong, Karin H. Yohem, Albert Leibovitz, Frank L. Meyskens, Dale H. Conaway, Danny R. Welch, L. A. Liotta, William G. Stetler‐Stevenson	153
20	Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line 1991 ·International Journal of Cancer ·Danny R. Welch, John Bisi, Bonnie E. Miller, Dale H. Conaway, Elisabeth A. Seftor, Karin H. Yohem, Linda Gilmore, Richard E.B. Seftor, Motowo Nakajima, Mary J.C. Hendrix	177

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact